-
1
-
-
8844219646
-
TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction
-
Akatsu, H., Yamagata, H., Chen, Y., Miki, T., Kamino, K., Takeda, M., Campbell, W., Kondo, I., Kosaka, K., Yamamoto, T., and Okada, H. 2004. TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction. Br. J. Haematol. 127: 440-447.
-
(2004)
Br. J. Haematol
, vol.127
, pp. 440-447
-
-
Akatsu, H.1
Yamagata, H.2
Chen, Y.3
Miki, T.4
Kamino, K.5
Takeda, M.6
Campbell, W.7
Kondo, I.8
Kosaka, K.9
Yamamoto, T.10
Okada, H.11
-
2
-
-
0029044322
-
Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor
-
Bajzar, L., Manuel, R., and Nesheim, M.E. 1995. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 270: 14477-14484.
-
(1995)
J. Biol. Chem
, vol.270
, pp. 14477-14484
-
-
Bajzar, L.1
Manuel, R.2
Nesheim, M.E.3
-
3
-
-
0029895009
-
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
-
Bajzar, L., Morser, J., and Nesheim, M. 1996. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271: 16603-16608.
-
(1996)
J. Biol. Chem
, vol.271
, pp. 16603-16608
-
-
Bajzar, L.1
Morser, J.2
Nesheim, M.3
-
4
-
-
0018889762
-
Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin
-
Belew, M., Gerdin, B., Lindeberg, G., Porath, J., Saldeen, T., and Wallin, R. 1980. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin. Biochim. Biophys. Acta 621: 169-178.
-
(1980)
Biochim. Biophys. Acta
, vol.621
, pp. 169-178
-
-
Belew, M.1
Gerdin, B.2
Lindeberg, G.3
Porath, J.4
Saldeen, T.5
Wallin, R.6
-
5
-
-
0037067719
-
A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitor
-
Boffa, M.B., Hamill, J.D., Bastajian, N., Dillon, R., Nesheim, M.E., and Koschinsky, M.L. 2002. A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 277: 25329-25336.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 25329-25336
-
-
Boffa, M.B.1
Hamill, J.D.2
Bastajian, N.3
Dillon, R.4
Nesheim, M.E.5
Koschinsky, M.L.6
-
6
-
-
0038660605
-
Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells
-
Boffa, M.B., Hamill, J.D., Maret, D., Brown, D., Scott, M.L., Nesheim, M.E., and Koschinsky, M.L. 2003. Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells. J. Biol. Chem. 278: 9250-9257.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 9250-9257
-
-
Boffa, M.B.1
Hamill, J.D.2
Maret, D.3
Brown, D.4
Scott, M.L.5
Nesheim, M.E.6
Koschinsky, M.L.7
-
7
-
-
0014900566
-
Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase
-
Bokisch, V.A., and Muller-Eberhard, H.J. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49: 2427-2436.
-
(1970)
J. Clin. Invest
, vol.49
, pp. 2427-2436
-
-
Bokisch, V.A.1
Muller-Eberhard, H.J.2
-
8
-
-
0035885942
-
A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels
-
Brouwers, G.J., Vos, H.L., Leebeek, F.W., Bulk, S., Schneider, M., Boffa, M., Koschinsky, M., van Tilburg, N.H., Nesheim, M.E., Bertina, R.M., and Gomez Garcia, E.B. 2001. A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels. Blood 98: 1992-1993.
-
(2001)
Blood
, vol.98
, pp. 1992-1993
-
-
Brouwers, G.J.1
Vos, H.L.2
Leebeek, F.W.3
Bulk, S.4
Schneider, M.5
Boffa, M.6
Koschinsky, M.7
van Tilburg, N.H.8
Nesheim, M.E.9
Bertina, R.M.10
Gomez Garcia, E.B.11
-
9
-
-
0024412863
-
An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits
-
Campbell, W., and Okada, H. 1989. An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem. Biophys. Res. Commun. 162: 933-939.
-
(1989)
Biochem. Biophys. Res. Commun
, vol.162
, pp. 933-939
-
-
Campbell, W.1
Okada, H.2
-
10
-
-
0025309851
-
An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis
-
Campbell, W., Yonezu, K., Shinohara, T., and Okada, H. 1990. An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis. J. Lab. Clin. Med. 115: 610-612.
-
(1990)
J. Lab. Clin. Med
, vol.115
, pp. 610-612
-
-
Campbell, W.1
Yonezu, K.2
Shinohara, T.3
Okada, H.4
-
11
-
-
0036191244
-
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N
-
Campbell, W.D., Lazoura, E., Okada, N., and Okada, H. 2002. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46: 131-134.
-
(2002)
Microbiol. Immunol
, vol.46
, pp. 131-134
-
-
Campbell, W.D.1
Lazoura, E.2
Okada, N.3
Okada, H.4
-
12
-
-
0034131501
-
Plasma TAFI antigen variations in healthy subjects
-
Chetaille, P., Alessi, M.C., Kouassi, D., Morange, P.E., and Juhan-Vague, I. 2000. Plasma TAFI antigen variations in healthy subjects. Thromb. Haemost. 83: 902-905.
-
(2000)
Thromb. Haemost
, vol.83
, pp. 902-905
-
-
Chetaille, P.1
Alessi, M.C.2
Kouassi, D.3
Morange, P.E.4
Juhan-Vague, I.5
-
13
-
-
17444368310
-
Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: A randomized-controlled study and review of the literature
-
Cosman, F., Baz-Hecht, M., Cushman, M., Vardy, M.D., Cruz, J.D., Nieves, J.W., Zion, M., and Lindsay, R. 2005. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thromb. Res. 116: 1-13.
-
(2005)
Thromb. Res
, vol.116
, pp. 1-13
-
-
Cosman, F.1
Baz-Hecht, M.2
Cushman, M.3
Vardy, M.D.4
Cruz, J.D.5
Nieves, J.W.6
Zion, M.7
Lindsay, R.8
-
14
-
-
0025748556
-
Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma
-
Eaton, D.L., Malloy, B.E., Tsai, S.P., Henzel, W., and Drayna, D. 1991. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266: 21833-21838.
-
(1991)
J. Biol. Chem
, vol.266
, pp. 21833-21838
-
-
Eaton, D.L.1
Malloy, B.E.2
Tsai, S.P.3
Henzel, W.4
Drayna, D.5
-
15
-
-
0000077897
-
An enzyme in human blood plasma that inactivates bradykinin and kallidins
-
Erdos, E.G., and Sloane, E.M. 1962. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11: 585-592.
-
(1962)
Biochem. Pharmacol
, vol.11
, pp. 585-592
-
-
Erdos, E.G.1
Sloane, E.M.2
-
16
-
-
0035351215
-
Identification of polymorphisms in the 5′- untranslated region of the TAFI gene: Relationship with plasma TAFI levels and risk of venous thrombosis
-
Franco, R.F., Fagundes, M.G., Meijers, J.C., Reitsma, P.H., Lourenco, D., Morelli, V., Maffei, F.H., Ferrari, I.C., Piccinato, C.E., Silva, W.A., Jr., and Zago, M.A. 2001. Identification of polymorphisms in the 5′- untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis. Haematologica 86: 510-517.
-
(2001)
Haematologica
, vol.86
, pp. 510-517
-
-
Franco, R.F.1
Fagundes, M.G.2
Meijers, J.C.3
Reitsma, P.H.4
Lourenco, D.5
Morelli, V.6
Maffei, F.H.7
Ferrari, I.C.8
Piccinato, C.E.9
Silva Jr., W.A.10
Zago, M.A.11
-
17
-
-
1542269664
-
Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: Comparison of different assays
-
Guimaraes, A.H., van Tilburg, N.H., Vos, H.L., Bertina, R.M., and Rijken, D.C. 2004. Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays. Br. J. Haematol. 124: 659-665.
-
(2004)
Br. J. Haematol
, vol.124
, pp. 659-665
-
-
Guimaraes, A.H.1
van Tilburg, N.H.2
Vos, H.L.3
Bertina, R.M.4
Rijken, D.C.5
-
18
-
-
84945736607
-
Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N
-
Hendriks, D., Scharpe, S., van Sande, M., and Lommaert, M.P. 1989. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J. Clin. Chem. Clin. Biochem. 27: 277-285.
-
(1989)
J. Clin. Chem. Clin. Biochem
, vol.27
, pp. 277-285
-
-
Hendriks, D.1
Scharpe, S.2
van Sande, M.3
Lommaert, M.P.4
-
19
-
-
0025255189
-
Purification and characterization of a new arginine carboxypeptidase in human serum
-
Hendriks, D., Wang, W., Scharpe, S., Lommaert, M.P., and van Sande, M. 1990. Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim. Biophys. Acta 1034: 86-92.
-
(1990)
Biochim. Biophys. Acta
, vol.1034
, pp. 86-92
-
-
Hendriks, D.1
Wang, W.2
Scharpe, S.3
Lommaert, M.P.4
van Sande, M.5
-
20
-
-
0035313252
-
Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: Evidence that plasma TAFI antigen levels are strongly genetically controlled
-
Henry, M., Aubert, H., Morange, P.E., Nanni, I., Alessi, M.C., Tiret, L., and Juhan-Vague, I. 2001. Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled. Blood 97: 2053-2058.
-
(2001)
Blood
, vol.97
, pp. 2053-2058
-
-
Henry, M.1
Aubert, H.2
Morange, P.E.3
Nanni, I.4
Alessi, M.C.5
Tiret, L.6
Juhan-Vague, I.7
-
21
-
-
0036091541
-
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe
-
Juhan-Vague, I., Morange, P.E., Aubert, H., Henry, M., Aillaud, M.F., Alessi, M.C., Samnegard, A., Hawe, E., Yudkin, J., Margaglione, M., Di Minno, G., Hamsten, A., and Humphries, S.E. 2002. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler. Thromb. Vasc. Biol. 22: 867-873.
-
(2002)
Arterioscler. Thromb. Vasc. Biol
, vol.22
, pp. 867-873
-
-
Juhan-Vague, I.1
Morange, P.E.2
Aubert, H.3
Henry, M.4
Aillaud, M.F.5
Alessi, M.C.6
Samnegard, A.7
Hawe, E.8
Yudkin, J.9
Margaglione, M.10
Di Minno, G.11
Hamsten, A.12
Humphries, S.E.13
-
22
-
-
0033813044
-
Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors
-
Juhan-Vague, I., Renucci, J.F., Grimaux, M., Morange, P.E., Gouvernet, J., Gourmelin, Y., and Alessi, M.C. 2000. Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors. Arterioscler. Thromb. Vasc. Biol. 20: 2156-2161.
-
(2000)
Arterioscler. Thromb. Vasc. Biol
, vol.20
, pp. 2156-2161
-
-
Juhan-Vague, I.1
Renucci, J.F.2
Grimaux, M.3
Morange, P.E.4
Gouvernet, J.5
Gourmelin, Y.6
Alessi, M.C.7
-
23
-
-
0345601770
-
Polymorphisms in the TAFI gene and the risk of venous thrombosis
-
Kostka, H., Kuhlisch, E., Schellong, S., and Siegert, G. 2003. Polymorphisms in the TAFI gene and the risk of venous thrombosis. Clin. Lab. 49: 645-647.
-
(2003)
Clin. Lab
, vol.49
, pp. 645-647
-
-
Kostka, H.1
Kuhlisch, E.2
Schellong, S.3
Siegert, G.4
-
24
-
-
0036493728
-
Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infection
-
Morange, P.E., Henry, M., Frere, C., and Juhan-Vague, I. 2002. Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infection. Blood 99: 1878-1879.
-
(2002)
Blood
, vol.99
, pp. 1878-1879
-
-
Morange, P.E.1
Henry, M.2
Frere, C.3
Juhan-Vague, I.4
-
25
-
-
0038454527
-
Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets
-
Mosnier, L.O., Buijtenhuijs, P., Marx, P.F., Meijers, J.C., and Bouma, B.N. 2003. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101: 4844-4846.
-
(2003)
Blood
, vol.101
, pp. 4844-4846
-
-
Mosnier, L.O.1
Buijtenhuijs, P.2
Marx, P.F.3
Meijers, J.C.4
Bouma, B.N.5
-
26
-
-
0035173479
-
Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin
-
Mosnier, L.O., Meijers, J.C., and Bouma, B.N. 2001. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb. Haemost. 85: 5-11.
-
(2001)
Thromb. Haemost
, vol.85
, pp. 5-11
-
-
Mosnier, L.O.1
Meijers, J.C.2
Bouma, B.N.3
-
27
-
-
25844522699
-
The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1
-
Ozeren, M., Karahan, S.C., Ozgur, M., Eminagaoglu, S., Unsal, M., Baytan, S., and Bozkaya, H. 2005. The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1. Acta Obstet. Gynecol. Scand. 84: 987-991.
-
(2005)
Acta Obstet. Gynecol. Scand
, vol.84
, pp. 987-991
-
-
Ozeren, M.1
Karahan, S.C.2
Ozgur, M.3
Eminagaoglu, S.4
Unsal, M.5
Baytan, S.6
Bozkaya, H.7
-
28
-
-
0036119128
-
Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): A randomized, placebo-controlled, 12-week study in early postmenopausal women
-
Post, M.S., Hendriks, D.F., Van Der Mooren, M.J., Van Baal, W.M., Leurs, J.R., Emeis, J.J., Kenemans, P., and Stehouwer, C.D. 2002. Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo-controlled, 12-week study in early postmenopausal women. J. Intern. Med. 251: 245-251.
-
(2002)
J. Intern. Med
, vol.251
, pp. 245-251
-
-
Post, M.S.1
Hendriks, D.F.2
Van Der Mooren, M.J.3
Van Baal, W.M.4
Leurs, J.R.5
Emeis, J.J.6
Kenemans, P.7
Stehouwer, C.D.8
-
29
-
-
6344233466
-
Tissue factor pathway inhibitor and thrombin activatable fibrinolytic inhibitor plasma levels following burn and septic injuries in rats
-
Ravindranath, T.M., Goto, M., Demir, M., Tobu, M., Kujawski, M.F., Hoppensteadt, D., Samonte, V., Iqbal, O., Sayeed, M.M., and Fareed, J. 2004. Tissue factor pathway inhibitor and thrombin activatable fibrinolytic inhibitor plasma levels following burn and septic injuries in rats. Clin. Appl. Thromb. Hemost. 10: 379-385.
-
(2004)
Clin. Appl. Thromb. Hemost
, vol.10
, pp. 379-385
-
-
Ravindranath, T.M.1
Goto, M.2
Demir, M.3
Tobu, M.4
Kujawski, M.F.5
Hoppensteadt, D.6
Samonte, V.7
Iqbal, O.8
Sayeed, M.M.9
Fareed, J.10
-
30
-
-
3242780163
-
Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level
-
Santamaria, A., Martinez-Rubio, A., Borrell, M., Mateo, J., Ortin, R., and Fontcuberta, J. 2004. Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level. Haematologica 89: 880-881.
-
(2004)
Haematologica
, vol.89
, pp. 880-881
-
-
Santamaria, A.1
Martinez-Rubio, A.2
Borrell, M.3
Mateo, J.4
Ortin, R.5
Fontcuberta, J.6
-
31
-
-
0034661975
-
Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not
-
Sato, T., Miwa, T., Akatsu, H., Matsukawa, N., Obata, K., Okada, N., Campbell, W., and Okada, H. 2000. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not. J. Immunol. 165: 1053-1058.
-
(2000)
J. Immunol
, vol.165
, pp. 1053-1058
-
-
Sato, T.1
Miwa, T.2
Akatsu, H.3
Matsukawa, N.4
Obata, K.5
Okada, N.6
Campbell, W.7
Okada, H.8
-
32
-
-
0037059828
-
Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme
-
Schneider, M., Boffa, M., Stewart, R., Rahman, M., Koschinsky, M., and Nesheim, M. 2002. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. J. Biol. Chem. 277: 1021-1030.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 1021-1030
-
-
Schneider, M.1
Boffa, M.2
Stewart, R.3
Rahman, M.4
Koschinsky, M.5
Nesheim, M.6
-
33
-
-
12244252240
-
Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography
-
Schroeder, V., Chatterjee, T., Mehta, H., Windecker, S., Pham, T., Devantay, N., Meier, B., and Kohler, H.P. 2002. Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thromb. Haemost. 88: 1020-1025.
-
(2002)
Thromb. Haemost
, vol.88
, pp. 1020-1025
-
-
Schroeder, V.1
Chatterjee, T.2
Mehta, H.3
Windecker, S.4
Pham, T.5
Devantay, N.6
Meier, B.7
Kohler, H.P.8
-
34
-
-
0028348825
-
Pro-carboxypeptidase R cleaves bradykinin following activation
-
Shinohara, T., Sakurada, C., Suzuki, T., Takeuchi, O., Campbell, W., Ikeda, S., Okada, N., and Okada, H. 1994. Pro-carboxypeptidase R cleaves bradykinin following activation. Int. Arch. Allergy Immunol. 103: 400-404.
-
(1994)
Int. Arch. Allergy Immunol
, vol.103
, pp. 400-404
-
-
Shinohara, T.1
Sakurada, C.2
Suzuki, T.3
Takeuchi, O.4
Campbell, W.5
Ikeda, S.6
Okada, N.7
Okada, H.8
-
35
-
-
0033832483
-
Plasma procarboxypeptidase U in men with symptomatic coronary artery disease
-
Silveira, A., Schatteman, K., Goossens, F., Moor, E., Scharpe, S., Stromqvist, M., Hendriks, D., and Hamsten, A. 2000. Plasma procarboxypeptidase U in men with symptomatic coronary artery disease. Thromb. Haemost. 84: 364-368.
-
(2000)
Thromb. Haemost
, vol.84
, pp. 364-368
-
-
Silveira, A.1
Schatteman, K.2
Goossens, F.3
Moor, E.4
Scharpe, S.5
Stromqvist, M.6
Hendriks, D.7
Hamsten, A.8
-
36
-
-
0037263617
-
Preferential detection of pro-carboxypeptidase R by enzyme-linked immunosorbent assay
-
Tani, S., Akatsu, H., Ishikawa, Y., Okada, N., and Okada, H. 2003. Preferential detection of pro-carboxypeptidase R by enzyme-linked immunosorbent assay. Microbiol. Immunol. 47: 295-300.
-
(2003)
Microbiol. Immunol
, vol.47
, pp. 295-300
-
-
Tani, S.1
Akatsu, H.2
Ishikawa, Y.3
Okada, N.4
Okada, H.5
-
37
-
-
0014375828
-
Degradation of human fibrinopeptides A and B in blood serum in vitro
-
Teger-Nilsson, A.C. 1968. Degradation of human fibrinopeptides A and B in blood serum in vitro. Acta Chem. Scand. 22: 3171-3182.
-
(1968)
Acta Chem. Scand
, vol.22
, pp. 3171-3182
-
-
Teger-Nilsson, A.C.1
-
38
-
-
0034839296
-
Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms
-
Tregouet, D.A., Aubert, H., Henry, M., Morange, P., Visvikis, S., Juhan-Vague, I., and Tiret, L. 2001. Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms. Hum. Genet. 109: 191-197.
-
(2001)
Hum. Genet
, vol.109
, pp. 191-197
-
-
Tregouet, D.A.1
Aubert, H.2
Henry, M.3
Morange, P.4
Visvikis, S.5
Juhan-Vague, I.6
Tiret, L.7
-
39
-
-
0034192129
-
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
-
van Tilburg, N.H., Rosendaal, F.R., and Bertina, R.M. 2000. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 95: 2855-2859.
-
(2000)
Blood
, vol.95
, pp. 2855-2859
-
-
van Tilburg, N.H.1
Rosendaal, F.R.2
Bertina, R.M.3
-
40
-
-
0035479232
-
Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation
-
Watanabe, R., Wada, H., Watanabe, Y., Sakakura, M., Nakasaki, T., Mori, Y., Nishikawa, M., Gabazza, E.C., Nobori, T., and Shiku, H. 2001. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. Thromb. Res. 104: 1-6.
-
(2001)
Thromb. Res
, vol.104
, pp. 1-6
-
-
Watanabe, R.1
Wada, H.2
Watanabe, Y.3
Sakakura, M.4
Nakasaki, T.5
Mori, Y.6
Nishikawa, M.7
Gabazza, E.C.8
Nobori, T.9
Shiku, H.10
-
41
-
-
0031766583
-
Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms
-
Zhao, L., Morser, J., Bajzar, L., Nesheim, M., and Nagashima, M. 1998. Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms. Thromb. Haemost. 80: 949-955.
-
(1998)
Thromb. Haemost
, vol.80
, pp. 949-955
-
-
Zhao, L.1
Morser, J.2
Bajzar, L.3
Nesheim, M.4
Nagashima, M.5
-
42
-
-
0141540528
-
Thrombinactivatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system
-
Zorio, E., Castello, R., Falco, C., Espana, F., Osa, A., Almenar, L., Aznar, J., and Estelles, A. 2003. Thrombinactivatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system. Br. J. Haematol. 122: 958-965.
-
(2003)
Br. J. Haematol
, vol.122
, pp. 958-965
-
-
Zorio, E.1
Castello, R.2
Falco, C.3
Espana, F.4
Osa, A.5
Almenar, L.6
Aznar, J.7
Estelles, A.8
|